Neuropsychological Functioning In Social Phobia by Sutterby, Scott
University of Central Florida 
STARS 
Electronic Theses and Dissertations, 2004-2019 
2009 
Neuropsychological Functioning In Social Phobia 
Scott Sutterby 
University of Central Florida 
 Part of the Psychology Commons 
Find similar works at: https://stars.library.ucf.edu/etd 
University of Central Florida Libraries http://library.ucf.edu 
This Masters Thesis (Open Access) is brought to you for free and open access by STARS. It has been accepted for 
inclusion in Electronic Theses and Dissertations, 2004-2019 by an authorized administrator of STARS. For more 
information, please contact STARS@ucf.edu. 
STARS Citation 
Sutterby, Scott, "Neuropsychological Functioning In Social Phobia" (2009). Electronic Theses and 
Dissertations, 2004-2019. 4126. 
https://stars.library.ucf.edu/etd/4126 
  
 
NEUROPSYCHOLOGICAL FUNCTIONING IN SOCIAL PHOBIA 
 
 
 
 
 
 
 
by 
 
 
 
SCOTT R. SUTTERBY 
B.A., University of Central Florida, 2006 
 
 
 
 
A thesis submitted in partial fulfillment of the requirements  
for the degree of Master of Science  
in the Department of Psychology  
in the College of Sciences 
at the University of Central Florida 
Orlando, Florida 
 
 
 
 
 
 
 
 
 
 
Fall Term 
2009 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2009 Scott R. Sutterby 
iii 
ABSTRACT 
The purpose of the current study was to clarify the neurocognitive mechanisms 
underlying social phobia. Previous research has identified some specific group differences in 
neurocognitive functioning between individuals diagnosed with social phobia and nonpsychiatric 
controls, but has failed to administer a comprehensive neuropsychological battery to a social 
phobia patient group, resulting in a piecemeal understanding of the neurocognitive functioning of 
this population and an incomplete picture of the neuropsychological profile inherent to this 
group. The present research utilized a broader collection of neuropsychological tests to assess 
nine cognitive domains: Verbal Learning, Verbal Delayed Memory, Visual Immediate Memory, 
Visual Delayed Memory, Visual-Spatial Processing, Verbal Working Memory, Visual Working 
Memory, Executive Functioning, and Attention. A mixed analysis of variance (ANOVA) did not 
reveal a significant group by cognitive domain interaction, nor a significant main effect of group. 
As this was the first study to examine multiple cognitive domains in a single sample of 
individuals with generalized social phobia, exploratory univariate analyses were performed to 
examine group differences for the specific cognitive domains. This revealed significant group 
differences specific to the Visual Working Memory domain, with the social phobia group scoring 
significantly lower than the nonpsychiatric control group. Implications of these findings and 
directions for future research are discussed. 
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INTRODUCTION 
Social phobia is a psychiatric disorder marked by persistent fears of social or 
performance situations in which embarrassment or negative evaluation by others may occur 
(American Psychiatric Association, 2000). These situations are often avoided, which leads to 
disability in social, educational, and occupational functioning. Social phobia is a chronic, usually 
lifelong, condition if not adequately treated. It typically begins in early adolescence, often 
emerging out of a pattern of shyness in earlier childhood. It is about twice as common in females 
and affects somewhere between 4% to 8% of the population, making it one of the most common 
psychiatric disorders (Kessler, 2003). Twin studies have established an underlying genetic 
component to this disorder (Kendler, Neale, Kessler, Heath, & Eaves, 1992). In addition, 
neuroimaging research has pointed to volumetric and functional brain differences related to 
social phobia. A number of studies have suggested a “highly sensitive fear network centered in 
the amygdaloid-hippocampal region and encompassing the prefrontal cortex” in individuals with 
social phobia (Tillfors, 2004, p. 273). In particular, significant differences in amygdala activation 
in social phobia has been well supported in the literature (e.g., Hermans & Honk, 2006; Straube, 
Mentzel, & Miltner, 2005; Veit et al., 2002). Amir et al. (2005) reported a significant increase in 
activity in the anterior cingulate cortex when individuals with social phobia viewed socially-
threatening material, as compared with non-anxious controls.  
 Current empirically-supported treatments for social phobia include both psychotherapy 
and medications. The treatment of social phobia has seen rapid advancement in recent years, and 
current estimates suggest that roughly 50% to 70% of individuals seeking treatment for social 
phobia are classified as treatment responders (Jørstad-Stein & Heimberg, 2009; Acarturk, 
Cuijpers, van Straten, & de Graaf, 2009). There remains, however, a minority of individuals who 
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experience only a partial reduction of their symptoms after treatment is discontinued. Moreover, 
a recent replication of the National Comorbidity Survey suggests that when social phobia cases 
are considered as a whole (i.e., both treated and untreated cases), full recovery may be a long 
process (Ruscio et al., 2008). Specifically, these authors reported that 20%-40% recover within 
twenty years of onset and 40%-60% recover within forty years of onset, when recovery is 
defined as greater than two years free of symptoms (Ruscio et al., 2008). These estimates may be 
somewhat inflated due to the fact that within the same sample only 35.2% of these cases reported 
ever receiving treatment specifically for social phobia, and that the number of social fears was 
inversely related to treatment-seeking among non-comorbid social phobia cases (Ruscio et al., 
2008). This does highlight a potentially important role for prevention approaches, however, as 
even the most efficacious treatments for social phobia cannot be implemented if these 
individuals are not presenting for treatment. Therefore, there is a need for research that clarifies 
the underlying mechanisms and etiology of this disorder, which can potentially inform new 
treatment and prevention components that seek to address these issues. 
 Neuropsychological evaluation is a method of inferring the functioning of particular brain 
networks without the need for expensive and invasive neuroimaging techniques. This approach 
uses paper-and-pencil and computer-based measures that have been previously established to 
correlate with functioning in particular brain regions. Neuropsychological research has been 
successfully used to elucidate neurobiological mechanisms involved with other psychiatric 
disorders over the past several decades, most notably with schizophrenia. These findings, in turn, 
have been translated into cognitive rehabilitation and remediation techniques that have proven to 
be effective components in the treatment of the disorder (see Cavallaro et al., 2009 for review). 
When considering anxiety disorders, recent studies have attempted to apply similar techniques to 
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determine neurocognitive profiles for specific disorders that can later be translated into 
treatment. For example, Amir, Beard, Burns, and Bomyea (2009) reported implementing a 
treatment paradigm that targeted the attention bias for threat-relevant information that is 
generally exhibited by individuals with generalized anxiety disorder. The results of their study 
suggested that these attention mechanisms contributed to the maintenance of GAD, and that 
interventions seeking to alter these processes may be effective in reducing anxiety symptoms in 
this population (Amir, Beard, Burns, & Bomyea, 2009). While research of this kind is still in the 
initial stages, it seems worthwhile to investigate whether underlying neurocognitive profiles of 
other specific disorders can be identified and targeted directly in an effort to bolster current 
treatment and prevention strategies. Unfortunately, these techniques have only rarely been used 
to further our understanding of social phobia.  
Although relatively little research to date has investigated the neuropsychological profiles 
of individuals with social phobia, there have been a few notable studies. Asmundson, Stein, 
Larsen, and Walker (1994) were among the first to publish neuropsychological findings for a 
group of patients diagnosed with social phobia. This group administered four subtests of the 
Wechsler Adult Intelligence Scale – Revised (WAIS-R; Vocabulary, Similarities, Block Design, 
and Picture Completion subtests) as well as the California Verbal Learning Test, the Benton 
Visual Retention Task – Form F, the Trail-Making Test, and the Digit Cancellation Test to panic 
disorder patients, social phobia patients, and nonpsychiatric controls. Asmundson et al. (1994) 
designed the battery to assess “verbal learning and memory, visual memory, psychomotor speed, 
cognitive flexibility, and concentration” (201). They found that both panic disorder and social 
phobia patients exhibited diminished performance on total recall for CVLT (Trials 1 through 5 
combined), but only the social phobia patients displayed deficits in the initial learning of the 
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verbal information when this component was examined separately (Trial 1). A non-significant 
trend of reduced accuracy on the concentration task (Digit Cancellation Test) was also noted for 
social phobia patients. In addition, both social phobia and panic disorder patients were noted to 
perform at a significantly lower level than nonpsychiatric controls on the Block Design subtest. 
No statistically significant differences were found between the three groups for visual memory, 
psychomotor speed, cognitive flexibility, or concentration in this sample. Their results suggested 
statistically significant decreased performance for both anxiety groups on particular 
neuropsychological measures, and a specific decrement in performance for social phobia patients 
on a task requiring free recall of verbal stimuli after a single presentation. 
 Cohen et al. (1996) also examined neuropsychological functioning in social phobia 
patients, and compared this group with both obsessive-compulsive disorder (OCD) patients and 
nonpsychiatric controls. These researchers assessed visuoconstructional functioning with the 
WAIS-R Block Design subtest, and visual memory with the Benton Visual Retention Test and 
the Matching Familiar Figures Test. The Matching Familiar Figures Test was also used as a 
measure of executive functioning (e.g., decision making and planning abilities), as was the Trail-
Making Test. The WAIS-R Digit Span subtest was administered to measure attention and 
memory, and the Digit Symbol subtest was administered as a nonspecific measure of 
functioning. Cohen et al. (1996) found that OCD patients showed significant impairment on the 
Digit Symbol subtest and the Benton Visual Retention Test. The social phobia patients 
performed significantly worse than controls on measures of visuoconstruction abilities (Block 
Design), visual memory (Benton Visual Retention Test), and a measure of visuospatial 
processing speed and executive functioning (Trails A and Trails B, respectively). Furthermore, 
social phobia patients displayed deficits in executive functioning (Trails B), even compared to 
5 
the OCD group. No other significant differences between the OCD and social phobia patient 
groups emerged, and there were no significant differences between any of the three groups on the 
Matching Familiar Figures Test or the Digit Span subtest. The authors concluded that different 
neuropsychological dysfunctions may be implicated in different anxiety disorders. 
 A slightly different approach was taken by Hollander et al. (1996) when they examined 
neurological „soft signs.‟ Neurological soft signs refer to abnormal performance on motor and 
sensory tasks that cannot be localized to a specific brain region. This study compared social 
phobia patients to nonpsychiatric controls across four domains: fine motor coordination, 
involuntary movements, sensory function, and a visuospatial (cube drawing) task (Hollander et 
al., 1996). The authors reported that social phobia patients had a greater number of neurological 
soft signs in the domains of fine motor coordination, involuntary movements, and visuospatial 
impairment – suggesting brain dysfunction related to social phobia. 
 In a 2004 study, Sachs et al. administered a brief, computerized neuropsychological 
battery as part of a larger event-related potential (ERP) study. This research group used the 
Wisconsin Card Sorting Test, the d2-cancellation test, the Verbal Learning Test and the Non-
Verbal Learning Test. These four tests were given to patients diagnosed with social phobia, and 
the results were compared with the performance of each test‟s published non-clinical normative 
sample. Sachs et al. (2004) found that the only significant differences in performance were found 
on the d2-cancellation test, which reflected decreased accuracy in focal attention and short-term 
concentration for the social phobia group. Executive functioning, verbal learning, and nonverbal 
learning appeared intact in this particular sample. 
Airaksinen, Larsson, and Forsell (2005) administered a 32-item, neutral word list to 
assess episodic memory, the Word Association Test to measure verbal fluency, and the Trail-
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Making Test to examine visuospatial processing speed and executive functioning. Several 
anxiety disorders were compared to a nonpsychiatric control group, including social phobia, 
panic disorder, generalized anxiety disorder, obsessive-compulsive disorder, and specific phobia. 
Deficits in episodic memory were found in the panic disorder, obsessive-compulsive disorder, 
and social phobia groups. Social phobia patients also showed a non-significant trend toward 
generating fewer words in the verbal fluency task. There were no statistically significant 
differences in performance among the six groups for Trails A (reflecting visuospatial processing 
speed). Only the panic disorder and obsessive-compulsive disorder groups showed significantly 
slower performance on the Trail-Making subtest that also included an executive functioning 
component (Trails B), as compared to the nonpsychiatric control group.  
 More recently, Graver and White (2007) administered the Wechsler Adult Intelligence 
Scale – Third Edition (WAIS-III) Digit Span subtest, Wechsler Memory Scale – Third Edition 
(WMS-III) Spatial Span subtest, the Trail-Making Test, and the Wisconsin Card Sorting Test 
(WCST) to a social phobia group, a comorbid social phobia and depression group, and a 
nonpsychiatric control group. Graver and White‟s test battery was designed to cover verbal 
attention, working memory, spatial memory, set shifting, and executive function. A unique 
aspect of the Graver and White (2007) study is the inclusion of a stress-induction condition. Each 
participant was administered the neuropsychological test battery twice: once under a baseline 
condition, and a second time under a stress-induction condition. In this study, stress was induced 
by informing participants that they were being videotaped for a training video intended for mass 
distribution, and that a red light on the recording equipment would signify when recording may 
take place. These researchers found no statistically significant differences among groups in the 
baseline condition. Under the stress condition, however, group differences began to emerge. The 
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social phobia patients showed less improvement on set-shifting and working memory tasks than 
the control and comorbid group during the stress (compared to baseline) condition (Trails B, 
Digit Span). The social phobia group also demonstrated a reduction in complex problem solving 
and spatial attention performance as compared to other groups after stress induction (WCST, 
Spatial Span).  
Taken together, the previous research on neuropsychological functioning related to social 
phobia reveals both similar and discrepant findings. All studies examining the domain of visual-
spatial processing reported decreased performance in individuals with social phobia, as 
evidenced by scores on Block Design (Asmundson et al., 1994; Cohen et al., 1996) and a cube 
drawing test (Hollander et al., 1996). Dysfunction in the verbal memory domain was suggested 
by Asmundson et al. (1994) and Airaksinen, Larsson, and Forsell (2005), although in both 
studies it appears that this dysfunction is not specific to social phobia, as it was also found in 
other anxiety disorders. Sachs et al. (2004) reported no significant differences for social phobia 
patients on the Verbal Learning Test, but it should be noted that this test differs from the verbal 
memory tasks used in the other studies because it involves recognition of meaningless words 
printed on cards as opposed to recall of actual words (Lakerveld, Kotchoubey, & Kübler, 2008). 
The Verbal Learning Test used in Sachs et al. (2004) should therefore be considered a measure 
of learning abilities free from context and not necessarily immediate verbal memory.  
In the domain of executive functioning, performance on both the Trail-Making Test 
(Trail B) and the Wisconsin Card Sorting Test has been examined. On the Trail-Making Test 
(Trail B), Asmundson et al. (1994), Airaksinen et al. (2005), and Graver and White (2007) found 
no significant differences in completion time for individuals with social phobia as compared to 
controls in baseline conditions. Cohen et al. (1996), however, reported that social phobia patients 
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had significantly longer completion times on this test. On the Wisconsin Card Sorting Test, 
Sachs et al. (2004), as well as Graver and White (2007), reported no significant differences for 
social phobia patients under baseline conditions.  
Mixed findings have also been present in the attention domain. Sachs et al. (2004) 
reported a statistically significant decrease in accuracy on the digit cancellation test for social 
phobia patients, and Asmundson et al. (1994) reported a non-significant trend toward reduced 
accuracy on a similar test. Both Cohen et al. (1996) and Graver and White (2007) found no 
significant differences in performance on the digit span forward subtest, however. The domains 
of verbal working memory and visual working memory appear to have been examined less often 
than other domains of neuropsychological functioning. Verbal working memory does not seem 
to have been fully addressed by previous research, and only one of the studies above 
administered a task related to the visual working memory domain. Graver and White (2007) 
reported no group differences on a visual working memory task (Spatial Span) in the baseline 
condition. 
As the existing literature on neuropsychological performance in individuals with social 
phobia is sparse and inconsistent, there is a need for research that clarifies the 
neuropsychological profile related to this disorder. None of the existing studies used a 
neuropsychological battery that examined a wide range of cognitive areas, which limits 
interpretation of the inconsistent results. While there was some overlap of cognitive areas 
examined (e.g., verbal memory, visual-spatial processing), the particular measures that were used 
typically varied as well. Research that uses a comprehensive neuropsychological battery in a 
single sample of individuals with social phobia is needed to clarify these previous reports. Before 
any of these findings can be translated into potential targets for treatment and prevention efforts, 
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the neurocognitive mechanisms underlying social phobia must be fully examined to determine 
whether a distinct neuropsychological profile for the disorder exists, and if so, where the deficits 
lie. This study aims to build upon these past findings and refine our understanding of the 
underlying mechanisms of social phobia. The current study will administer a neuropsychological 
test battery to a sample of individuals who meet DSM-IV diagnostic criteria for generalized 
social phobia and a sample of nonpsychiatric controls. The neuropsychological battery will 
examine the domains of verbal and visual memory, visual-spatial processing, verbal and visual 
working memory, executive functioning, and attention. 
Based on the limited published findings regarding the neuropsychological functioning of 
social phobia patients, we hypothesize that the social phobia participants will show a statistically 
significant reduction in performance, compared to nonpsychiatric controls, in the domains of 
verbal learning and visual-spatial processing. This is based on the few areas of overlap and 
potential agreement in the extant literature, which suggests a greater probability of true 
differences in performance between social phobia patients and nonpsychiatric controls in these 
particular cognitive domains. 
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 METHOD 
Participants 
Previous research using tasks similar to those in the current study (described in detail 
below) have all reported relatively large effect sizes. Specifically, studies administering the 
Block Design subtest, Trail Making Test (Trails A and B), and California Verbal Learning Test 
(Trials 1-5) reported Cohen‟s d effect sizes ranging from 0.81 to 1.41. When using a similar 
effect size (d = .80) in a power analysis (G*Power software), with an alpha of .05, and power of 
.80, the estimated total sample size (both groups combined) was suggested as 42. Our combined 
sample size (social phobia group plus nonpsychiatric control group) was 50, which exceeds this 
suggested sample size and should provide sufficient power to find the quantitative group 
difference on these measures of interest.  
This study recruited adult participants from the local community, with the goal of 
obtaining two groups: 25 individuals who meet criteria for generalized social phobia and 25 
participants to serve as nonpsychiatric controls. Participants were recruited through use of 
advertisements in newspapers and websites, word of mouth from previous participants, and 
posted flyers in the community. Some of the advertisements targeted individuals who were likely 
to have social phobia, while others targeted nonpsychiatric control participants. We paid all 
participants $10 per half hour of participation as an incentive to travel to the university and 
participate in this research. The full assessment session typically lasted between 2 and 2.5 hours 
per participant.   
We obtained verbal informed consent and conducted a brief phone screen on all 
individuals who responded to our advertisements. This served to screen out individuals who did 
not seem appropriate for the diagnostic categories, as well as individuals reporting a history of 
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neurological illness, traumatic brain injury, or other self-reported psychiatric illness or treatment 
(see Appendix D). All participants were at least 18 years of age and the upper age limit was set at 
65. There were no restrictions based on gender, race, or ethnicity. We did, however, match the 
demographics of the control group to those of the social phobia group (see Table 1). 
Participants passing the phone screen mentioned above were then invited to participate in 
a research session held in the Psychology Building on campus. If individuals recruited for the 
social phobia group did not meet diagnostic criteria based on our structured clinical interview 
(see Measures below), they were paid for their time but did not complete the cognitive testing. 
Individuals in the social phobia group with comorbid psychiatric diagnoses were excluded, with 
an allowance for comorbid specific phobia. Similarly, if individuals recruited for the 
nonpsychiatric control group met criteria for a current psychiatric illness (with an allowance for 
specific phobia) they did not complete cognitive testing. Throughout the course of the present 
study, a total of six individuals were discontinued for not meeting diagnostic criteria. In the 
current sample, two participants in the social phobia group (8% of the social phobia group) and 
one participant in the control group (4% of the control group) met criteria for a specific phobia. 
The only past diagnoses allowed in either group were adjustment disorder, substance abuse (with 
none in past month), specific phobia, and major depressive disorder in full remission. All 
participants in the current study had normal or corrected-to-normal vision, were free from 
significant hearing problems, and had English as their primary language. Participants reporting a 
history of significant head injury (loss of consciousness greater than 10 minutes), neurological 
illness (e.g., stroke, seizures, brain tumor, Parkinson‟s), or systematic medical diseases that may 
affect neurocognitive functioning (e.g., active AIDS, lupus, congestive heart disease, insulin-
dependent diabetes) were excluded from the study. Participants in either group who were 
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currently prescribed benzodiazepines, tranquilizers, anti-psychotics, or narcotic pain medications 
were also excluded, as these medications have a strong potential to decrease cognitive 
performance. Participants prescribed other classes of psychotropic medication (e.g., anti-
depressants, stimulants) were not excluded from either group. In the current sample, none of the 
participants in either group endorsed being prescribed psychotropic medication of any kind. 
Participants reporting significant alcohol consumption or any other substance use within the past 
48 hours were excluded, as this may alter the results of cognitive testing.   
 
Measures 
 The measures for this study were selected in order to diagnose psychopathology and 
create a comprehensive neuropsychological battery. Each of the neuropsychological measures 
fell under one of nine domains: Verbal Learning, Verbal Delayed Memory, Visual Immediate 
Memory, Visual Delayed Memory, Visual-Spatial Processing, Verbal Working Memory, Visual 
Working Memory, Executive Functioning, and Attention. Each measure is described in detail 
below, and the measures composing the neuropsychological battery each include the name of the 
domain that they fall under. Table 2 summarizes the measures which comprise each domain. 
Anxiety Disorders Interview Schedule – IV (ADIS-IV). 
The ADIS-IV (Brown, DiNardo, & Barlow, 1994) is a structured clinical 
interview that assesses for anxiety symptoms. This interview is aimed at providing 
differential diagnosis among the anxiety disorders according to DSM-IV criteria. Mood 
disorders, somatoform disorders, and substance use are also assessed by the ADIS-IV due 
to the high comorbidity of these issues with anxiety disorders. In addition, the ADIS-IV 
contains a screen for psychosis. A clinical severity rating (CSR) is assigned for each 
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diagnosis identified by the ADIS-IV, which ranges from zero (0; absent or no distress) to 
eight (8; very severely disturbing or disabling). According to the ADIS-IV Clinician 
Manual (Brown, DiNardo, & Barlow, 1994), severity ratings of four or above indicate 
that the individual‟s symptom presentation meets or exceeds DSM-IV diagnostic criteria. 
In the current study, the ADIS-IV was used to assess which participants met criteria for 
the social phobia group, and was used to exclude participants from both groups with 
disorders that may have served as confounds to the study (see Exclusion criteria above). 
 Social Phobia and Anxiety Inventory – 23 (SPAI-23). 
The SPAI-23 (Roberson-Nay, Strong, Nay, Beidel, & Turner, 2007) is a 23-item 
self-report measure that assesses social phobia symptoms, and is an abbreviated version 
of the original 45-item SPAI (Turner, Beidel, & Dancu, 1996). Cognitive, behavioral, and 
somatic symptoms of social phobia across a variety of situations are assessed by the 
SPAI-23. This measure is comprised of two subscales: Social Phobia and Agoraphobia. 
The use of the Agoraphobia subscale is notable because this is subtracted from the Social 
Phobia subscale score in order to derive a difference score. The result is “a purer measure 
of social phobia” (p.2; Turner, Beidel, & Dancu, 1996). The authors cite excellent 
psychometric properties, including high internal consistency and discriminant validity, as 
well as high correlation with the original form of the SPAI. This measure was used in 
conjunction with the structured interview in order to estimate the severity of participants‟ 
social phobia symptoms. 
State-Trait Anxiety Inventory (STAI). 
The STAI (Spielberger et al., 1983) is a self-report measure that assesses both 
transient („state‟) anxiety and more pervasive, characteristic („trait‟) anxiety. The STAI 
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was used in the present study to assess each participant‟s current anxiety level during the 
assessment session, as well as self-reported trait anxiety level. 
Wechsler Adult Intelligence – III (WAIS-III) Subtests (Wechsler, 1997a). 
Block Design. 
 The Block Design subtest involves having participants physically 
manipulate and arrange blocks in order to match printed designs. This subtest 
emphasizes visuoconstruction abilities. As such, the total raw score on Block 
Design fell under the Visual-Spatial Processing domain. 
Wechsler Memory Scale – III (WMS-III) Subtests (Wechsler, 1997b). 
Family Pictures I & II. 
The Family Pictures I & II subtests involves showing pictures to 
participants, and then examining both immediate (Family Pictures I) and delayed 
(Family Pictures II) recall of characters and activities shown in each scene. This 
study used the total raw score from Family Pictures I for the Visual Immediate 
Memory domain and the total raw score from Family Pictures II for the Visual 
Delayed Memory domain. 
Word Lists I & II. 
Word Lists I & II involve reading lists of words to participants, and then 
examining both immediate (Word Lists I) and delayed (Word Lists II) recall of 
the words. Word Lists II also has a recognition condition, which was not used for 
analysis. In the current study, the total immediate recall raw score from the Word 
Lists I subtest was used for the Verbal Learning score and the total delayed recall 
15 
raw score from the Word Lists II subtest was used for the Delayed Verbal 
Memory score.  
Letter-Number Sequencing. 
The Letter-Numbering Sequencing subtest involves listening to a list of a 
random letters and numbers, holding them in memory, manipulating them into a 
new order, and then stating the new sequence aloud. The Letter-Numbering 
Sequencing total raw score fell under the Verbal Working Memory domain in the 
present study. 
Spatial Span. 
The Spatial Span subtest requires participants to touch a series of three-
dimensional blocks in a prescribed order (both forward and backward conditions), 
in increasingly long series. This task requires participants to retain and manipulate 
nonverbal information in their working memory, and as such the total raw score 
on this measure fell under the Visual Working Memory domain. 
Digit Span (Forward). 
The Digit Span (Forward) subtest asks participants to listen to a list a 
numbers and then immediately repeat them aloud in the order presented. This 
subtest is widely considered a measure of attention because it does not require 
participants to manipulate the information in any way. As such, the Digit Span 
(Forward) subtest raw score fell under the Attention domain in the present study. 
Rey Complex Figure Test (Copy). 
The copy condition of the Rey Complex Figure Test (Meyers & Meyers, 1996) 
presents participants with a complex geometric design, and requires them to precisely 
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draw the figure while it is directly in front of them. This test examines visuoconstructive 
abilities, and the total raw score was included in the Visual-Spatial Processing domain in 
the current study. 
Trail-Making Test (TMT). 
The TMT (Reitan & Wolfson, 1985) is split into two portions: A and B. In Trails 
A, individuals must draw lines connecting a set of consecutively numbered circles. Trails 
B is similar, but includes a set-shifting component that requires participants to alternate 
between numbers and letters. In both conditions, the score is based on the speed in which 
the participant completes the task. If the participant makes an error, the examiner requires 
that they stop and correct the error, which delays the completion time. In the present 
study, Trails A completion time was included under the Attention domain, and Trails B 
completion time fell under the Executive Functioning domain. The placement of Trails A 
and Trails B into these domains reflects the currently accepted clinical and research 
applications for the TMT (Heaton, Miller, Taylor, & Grant, 2004). 
Stroop Task. 
Several variations of the Stroop task exist. The current study employed a three 
condition (congruent, incongruent, and neutral) Stroop task with four color choices- red, 
green, blue, and yellow. During the neutral condition, a row of four “X‟s” appears in one 
of the four colors. The neutral condition serves as baseline measure of reaction time of 
simply responding to color, since there is no reading component and thus no interference 
during neutral trials. During the congruent condition, a color word appears in matching, 
or congruent font color (i.e. the word RED appears in red font). During the incongruent 
task, the color word and the actual color of the font is different (i.e. the word GREEN 
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written in red font). The incongruent trials require the participant to suppress the habitual 
reading response, thus creating interference. Since the participant must inhibit the 
automatic reaction of simply reading the word, the contrast score from this task 
(incongruent reaction time – congruent reaction time) was included in the Executive 
Functioning domain. 
 
Procedures 
After providing written informed consent, participants were administered the ADIS-IV to 
assess for anxiety symptoms and other psychopathology. All ADIS-IV interviews were 
conducted by the primary investigator, who was not blind to the screening process. After the 
diagnostic interview participants completed the SPAI-23 and STAI questionnaires. They were 
then administered the neuropsychological testing battery, consisting of the cognitive tasks listed 
above. The tasks were presented in a fixed order: Family Pictures I, Word Lists I, Letter-Number 
Sequencing, Spatial Span, Digit Span (Forward), Block Design, Trail-Making Test (A & B), Rey 
Complex Figure Test, Family Pictures II, Word Lists II, and the Stroop Task. At the end of the 
testing, participants were paid for their time and provided with a debriefing statement that 
discussed the purpose of the study. All participants were also provided with a list of treatment 
referral sources in the event that they wished to seek psychological services. 
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RESULTS 
Clinical Interview Data 
 An estimate of diagnosis accuracy was obtained using a procedure modeled after Turner, 
Beidel, Long, and Greenhouse (1992). All ADIS-IV interviews were recorded as digital audio 
files and stripped of all personally identifying data. Thirteen of these files (6 from the 
nonpsychiatric control group and 7 from the social phobia group; 26% of the total sample) were 
randomly selected to be evaluated by an independent researcher not associated with the present 
study. The independent evaluator confirmed all final diagnoses and subsequent assignment to 
either the social phobia or nonpsychiatric control group in each of these cases, thus resulting in 
an estimated reliability coefficient of κ = 1. Individuals in the social phobia group received 
significantly higher clinical severity ratings (CSRs) in regard to symptoms of social anxiety as 
compared to the control group [t(48) = 26.57, p < .001]. Four participants in the control group 
did not receive a CSR of zero, and a closer inspection of these cases revealed that all of these 
participants endorsed mild, subthreshold anxiety symptoms specific to public speaking 
situations. Means, standard deviations, and ranges for each group on these measures are reported 
in Table 1.  
 
Self-Report Questionnaires 
 Questionnaire data were examined to determine differences between the two groups in 
self-reported levels of anxiety. As expected, individuals in the social phobia group reported 
significantly higher levels of anxiety on the SPAI-23 Social Phobia subscale [t(48) = 11.199, p < 
.001] and SPAI-23 Agoraphobia subscale [t(48) = 6.037, p < .001]. The SPAI-23 Difference 
Score was also significantly higher for the social phobia group [t(48) = 8.772, p <.001]. 
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Similarly, individuals in the social phobia group received significantly higher scores on both the 
STAI-State [t(48) = 11.446, p < .01] and STAI-Trait [t(48) = 9.289, p < .001] measures. Means, 
standard deviations, and ranges for each group on these measures are reported in Table 1.   
 
Cognitive Tasks 
All raw test scores from the cognitive tasks were transformed into z-scores using the 
means and standard deviation values from the nonpsychiatric control group as norm scores. The 
resulting z-scores were then averaged to create scores for each of the nine cognitive domains: 
Verbal Learning, Verbal Delayed Memory, Visual Immediate Memory, Visual Delayed 
Memory, Visual-Spatial Processing, Verbal Working Memory, Visual Working Memory, 
Executive Functioning, and Attention. These domain scores were used as dependent variables in 
a mixed analysis of variance (ANOVA) with group (social phobia, nonpsychiatric controls) 
serving as the between-subjects variable and cognitive domain serving as the within-subjects 
factor. This analysis did not reveal a significant group by cognitive domain interaction (F(8,41) = 
1.335, p = .254, η2 = .207), nor a significant main effect of group (F(1,48) = .566, p = .456, η2 = 
.012). The main effect of cognitive domain was the same as the domain by group interaction due 
to the fact that the control group had a mean z-score of zero across all domains. 
As this was the first study to examine multiple cognitive domains in a single sample of 
individuals with social phobia, exploratory univariate analyses were performed to examine group 
differences for the specific cognitive domains (see Table 3). This revealed significant group 
differences in only the Visual Working Memory domain [t(48) = 2.043, p = .047, d = 0.578], 
with the social phobia group scoring significantly lower than the nonpsychiatric control group. 
This difference did not survive a conservative Bonferroni correction for the multiple 
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comparisons, however. This group difference was further evaluated by examining each subtest 
within the Visual Working Memory domain. Significant differences were found for both Spatial 
Span Total score [t(48) = 2.043, p = .047, d = 0.578] and Spatial Span Backward score [t(48) = 
2.436, p = .019, d = 0.689; see Figure 1], but not for Spatial Span Forward score [t(48) = 0.809, p 
= .423, d = 0.229], with individuals in the social phobia group having lower scores than the 
nonpsychiatric control group on all measures.  
The role of symptom severity in relation to performance on the Spatial Span task was 
also assessed by using Spatial Span Total score as the dependent variable in a linear regression 
with group (social phobia, nonpsychiatric controls) and the SPAI-23 Difference score as 
predictors. This analysis revealed a nonsignificant trend toward a group by SPAI-23 Difference 
score interaction (F(1,46) = 3.004, p = .090, η2 = .061), so Spatial Span Backward and Spatial 
Span Forward scores were also examined separately. When a similar analysis was run using 
Spatial Span Backward score as the dependent variable, the group by SPAI-23 Difference score 
interaction was not significant (F(1,46) = 1.120, p = .295, η2 = .024). The main effects of both 
group (F(1,46) = 2.760, p = .130, η2 = .057) and SPAI-23 Difference score (F(1,46) = 0.243, p = 
.624, η2 = .005) were also not statistically significant. Spatial Span Forward score was also 
examined separately, and this analysis revealed a significant group by SPAI-23 Difference score 
interaction (F(1,46) = 5.057, p = .029, η2 = .099; see Figure 2). An examination of simple effects 
indicated a significant negative correlation between Spatial Span Forward score and SPAI-23 
Difference score for the control group only (r = -.423, p = .035); this pattern was not observed in 
the social phobia group (r = .194, p = .354). 
Since there was an a priori hypothesis for the groups to differ on the Verbal Learning and 
Visual-Spatial Processing domains in particular, the subtests of these domains were further 
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explored. No significant differences between the social phobia group and nonpsychiatric control 
group emerged on the Word Lists I Recall score [t(48) = 0.626, p = .535, d = 0.177], Block 
Design score [t(48) = 0.388, p = .699, d = 0.110], or RCFT-Copy score [t(48) = 0.670, p = .947, 
d = 0.019].  
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DISCUSSION 
The purpose of the current study was to clarify the neurocognitive mechanisms 
underlying social phobia. Previous research in this area has identified some specific group 
differences in neurocognitive functioning between individuals diagnosed with social phobia and 
nonpsychiatric controls, but has failed to administer a comprehensive neuropsychological battery 
to a social phobia patient group. This has resulted in a piecemeal understanding of the 
neurocognitive functioning of this population and an incomplete picture of the 
neuropsychological profile inherent to this group. The present research utilized a broader 
collection of neuropsychological tests to assess a wide range of functioning in individuals with 
generalized social phobia. Specifically, the domains of verbal and visual memory (both 
immediate and delayed), visual-spatial processing, verbal and visual working memory, executive 
functioning, and attention were examined.  
Based on the limited published findings regarding the neuropsychological functioning of 
social phobia patients, we hypothesized that the social phobia participants would show a 
statistically significant reduction in performance, compared to nonpsychiatric controls, in the 
domains of Verbal Learning and Visual-Spatial Processing. This was based on the few areas of 
overlap and potential agreement in the extant literature, which suggested a greater probability of 
true differences in performance between social phobia patients and nonpsychiatric controls in 
these particular cognitive domains. Results obtained from the current sample, however, failed to 
support both of these hypotheses.  
The lack of a deficit in the Verbal Memory domains appears to be in conflict with the 
previous findings reported by Asmundson et al. (1994) and Airaksinen, Larsson, and Forsell 
(2005). In the Asmundson et al. (1994) study, the CVLT was administered to individuals with 
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social phobia. This test is very similar to the WMS-III Word Lists I and II tasks administered in 
the present study, as both require learning a word list presented over multiple trials and then an 
immediate, short delay, and long delay recall. Both tasks also include a forced-choice recognition 
trial. While Asmundson and colleagues (1994) reported deficits specific to the immediate 
learning of the CVLT word list (i.e., total immediate recall score for trials one through five), 
these findings were not replicated in the current study when an analogous score was examined 
(i.e., Word Lists I immediate recall). These discrepant findings may be due to differences 
between the current sample and that of the Asmundson (1994) study, but may also be attributable 
in part to a key difference between the word lists used in these two tasks - which is addressed 
further below.  
Airaksinen, Larsson, and Forsell (2005) assessed verbal memory through presentation of 
a word list consisting of thirty-two neutral words followed by an immediate recall trial. Again, 
these researchers reported statistically significant deficits in performance for the social phobia 
group in both the immediate free and cued recall trials. It is important to note here that this task 
differs from the WMS-III Word Lists tasks because it relies on a single presentation of a longer 
word list; it is not designed to assess verbal learning across multiple trials. Furthermore, the word 
lists used in both the Asmundson et al. (1994) and Airaksinen, Larsson, and Forsell (2005) 
studies contain words that can be grouped into distinct taxonomic categories, and decreased 
performance in the recall of these lists may be due to a deficit in mnemonic strategy among 
individuals with social phobia rather than a global decreased ability in immediate verbal 
memory. The word list used in the WMS-III cannot easily be grouped into taxonomic categories, 
and it may be the case that immediate free recall of unrelated words is equally difficult for both 
individuals with social phobia and nonpsychiatric controls. In the present study, each group 
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recalled roughly sixty-eight percent of the words presented on the immediate free recall trial. 
Due to the relative paucity of reported findings in verbal memory for individuals with social 
phobia, further research will be necessary to determine whether such deficits are common 
correlates of this disorder. 
The current study also did not find decreased performance among patients with social 
phobia in the Visual-Spatial Processing domain. This finding also is inconsistent with previous 
research. Both Asmundson et al. (1994) and Cohen et al. (1996) reported deficits on WAIS 
Block Design scores for individuals with social phobia when compared to nonpsychiatric 
controls, but this finding was not replicated in the present sample when using the same subtest. 
The effect sizes from the Asmundson et al. (1994) and Cohen et al. (1996) studies were relatively 
large, with Cohen‟s d effect sizes ranging from 0.8 to 0.9, indicating that the sample size in the 
current study should have provided adequate power to detect group differences. Hollander et al. 
(1996) reported decreased performance of patients with social phobia relative to nonpsychiatric 
controls on a cube drawing test meant to assess neurological soft signs. The cube drawing task is 
similar to the RCFT-Copy task used in the present research, but again no significant differences 
in RCFT-Copy performance emerged between individuals with social phobia and the 
nonpsychiatric control group. It remains unclear why no significant differences between groups 
were found on tasks within this domain, particularly with regard to the WAIS Block Design 
subtest. Additional research is necessary to clarify the manner and extent to which visual-spatial 
processing deficits are related to social phobia.  
Significant deficits in performance for the social phobia group were found, however, in 
the Visual Working Memory domain. Again, interpretation of these findings is tentative at best 
because these significant group differences did not survive a conservative Bonferroni correction 
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for multiple comparisons. Individuals with social phobia scored significantly lower than 
nonpsychiatric controls in the current sample on the WMS-III Spatial Span task, and this 
decrease in performance was especially pronounced for the Spatial Span Backward task. 
Performance on the Spatial Span task was further examined in relation to symptom severity. This 
analysis revealed a nonsignificant trend toward a group by SPAI-23 Difference score interaction 
on the Spatial Span Total score, so Spatial Span Forward and Backward scores were also 
examined in relation symptom severity. Interestingly, there was a significant interaction between 
group and SPAI-23 Difference score on the Spatial Span Forward score. An examination of 
simple effects revealed a significant negative correlation between Spatial Span Forward score 
and SPAI-23 Difference score for the control group only, such that increased self-reported social 
anxiety symptoms were associated with decreased performance on the Spatial Span Forward 
task. This pattern was not evident with the social phobia group, however. There was no 
suggestion of a similar interaction between group and Spatial Span Backward score, nor were 
there significant main effects for SPAI-23 Difference score under this condition. The Spatial 
Span Forward task is considered a measure of focal visual attention and passive visual memory 
storage, and it could be that the decreased performance in relation to increased self-reported 
social anxiety symptoms is present only for mild to moderate levels of social anxiety. Individuals 
experiencing moderate to severe levels of social anxiety, like those in the social phobia group in 
the present study, may not exhibit the same effect. These initial findings and interpretations 
remain speculative, however, due to the lack of statistical significance after multiple-
comparisons correction. Further research is needed to disentangle the relationship between level 
of social anxiety symptoms and performance on similar visual tasks. 
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The Graver and White (2007) article has been the only previously published study to 
administer the WMS-III Spatial Span task to a social phobia patient group. These researchers 
reported that while there were no significant differences between groups in their baseline 
condition, significant effects emerged when the task was administered under induced stress. 
Specifically, control subjects improved performance from baseline conditions when they were 
re-administered the Spatial Span test under the stress-induction condition, whereas individuals 
with social phobia showed decreased performance relative to themselves in the stress-induction 
condition versus the baseline condition. This effect could be secondary to differences in baseline 
levels of arousal between the two groups; the stress condition may have served to raise arousal 
levels and enhance performance in the control group, whereas raising the already heightened 
arousal level of the social phobia participants served to decrease performance (i.e., the Yerkes-
Dodson effect; see Calabrese, 2008 for review).     
The finding of decreased performance within the Visual Working Memory domain for 
the social phobia group is particularly interesting in light of the previous neuropsychological 
findings for this population. While there remains some question as to the specific neurocognitive 
correlates of this disorder, the results from the current study lend tentative support to a small, yet 
growing body of literature suggesting impaired performances on tasks falling within the broad 
domain of visual abilities. If a visual working memory deficit actually does exist, this would 
have a number of implications for individuals with social phobia. If an individual exhibits poor 
working memory of nonverbal social cues, for example, this could lead to further disruption in 
social performance and decreased confidence in social situations due in part to an inability to 
simultaneously process and interpret the many nonverbal cues present in any one social 
exchange. Furthermore, the accurate assessment of feedback from others across situations would 
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be greatly complicated by decreased visual working memory abilities as new visual information 
may not be effectively consolidated and incorporated into an individual‟s overall perception of 
social interactions. It could be the case that an intervention which focuses on the development of 
enhanced visual working memory strategies may serve to disrupt some of these processes, which 
may then help to lower overall anxiety in these social situations. More research based on these 
preliminary findings needs to be conducted before any conclusions can be drawn as to whether 
such an intervention would be an effective component of a larger treatment plan.  
The present research has several limitations. First, all ADIS-IV interviews were 
administered by the primary investigator, who was not blind to the screening process. Although 
an attempt was made to estimate diagnosis accuracy through use of an independent rater who 
was blind to the screening process, this procedure was only completed with a subset of the 
sample and ultimately may have impacted the assignment of participants into their respective 
groups.  Furthermore, the community sample used in the current study may have represented a 
set of individuals with less severe symptomatology and higher functioning than is typically seen 
in clinical settings. For example, the ADIS-IV clinical severity ratings (CSRs) in the social 
phobia group ranged from four to six (M = 4.56), despite the fact that the CSR scale extends to a 
rating of eight and that a rating four is generally considered the minimum CSR for those meeting 
full diagnostic criteria. Moreover, the SPAI-23 Difference score in the social phobia group (M = 
44.04, SD = 8.64, range = 30-70) reflected both a lower mean and a narrower range when 
compared with the original SPAI Difference scores of the clinical sample in the normative group 
for that measure (M = 95.77, SD = 32.55, range = 15-160.67; Roberson-Nay, Strong, Nay, 
Beidel, & Turner, 2007). This may partially explain why the neuropsychological functioning of 
the social phobia group was not significantly different from the nonpsychiatric control group on 
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the majority of the tasks in the present study, but future research examining more severe clinical 
samples is necessary before drawing any conclusions of this nature. The present research was 
also limited by the inclusion of only a single task examining the Visual Working Memory 
domain as well as single tasks assessing the domains of Visual Immediate Memory and Visual 
Delayed Memory, respectively. Only one other study with a social phobia sample has included a 
measure of visual working memory (Graver & White, 2007), and no published study to date on 
this disorder has included a measure of delayed visual memory. Future research should be 
directed toward a more complete assessment of visual abilities in individuals with social phobia, 
including multiple measures of visual-spatial processing as well as working, immediate, and 
delayed visual memory, with the aim of gaining a more thorough understanding of the specific 
difficulties within the visual domain experienced by this population.  Additionally, it will be 
important to include measures of emotional identification and recognition, as well as broader 
measures of social cognition, which may be related to cognitive deficits in the visual domain as 
well as difficulties with social processing among individuals with social phobia. Research can 
then move toward uncovering how these mechanisms are related to the development and 
maintenance of the disorder, so that any specific neuropsychological deficits can be targeted 
directly and potentially be included as a component in the effective treatment and prevention of 
social phobia. 
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APPENDIX A: TABLES 
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Table 1  
Demographic and Clinical Characteristics 
 
Measure 
Social Phobia Group  
(n = 25) 
Nonpsychiatric Control Group  
(n = 25) 
 
Gender (male)
a 
 
52% 52% 
Age 38.04 (12.85) 38.60 (12.10) 
Years of Education 14.40 (1.73) 14.56 (1.71) 
Race: Caucasian
 a
 68% 68% 
Race: Hispanic/Latino
 a
 16% 8% 
Race: Black/African American
 a
 8% 12% 
Race: Asian
 a
 4% 12% 
Race: Multiracial/Other
 a
 4% 0% 
ADIS-IV: CSR 4.56 (0.65)**; range = 4 – 6  0.20 (0.50)**; range = 0 – 2  
SPAI-23: Social Phobia 63.60 (8.54)**; range = 37 – 78  30.56 (12.03)**; range = 16 – 55  
SPAI-23: Agoraphobia 19.56 (5.72)**; range = 7 – 30  10.20 (5.24)**; range = 7 – 25  
SPAI-23: Difference Score 44.04 (8.64)**; range = 30 – 70  20.36 (10.37)**; range = 9 – 46 
STAI: State 49.76 (8.96)**; range = 26 – 64  25.52 (5.64)**; range = 20 – 45  
STAI: Trait 57.28 (11.13)**; range = 28 – 72  31.44 (8.35)**; range = 20 – 56  
     *p < .05; **p < .001 
Values represent means and standard deviations for all variables except for those notated (
a
 indicates a percentage) 
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Table 2  
Cognitive Domains and Measures 
                                                                                                                 
Verbal Learning 
Word Lists I  
Verbal Delayed Memory 
      Word Lists II 
Visual Immediate Memory 
      Family Pictures I  
Visual Delayed Memory 
      Family Pictures II 
Visual-Spatial Processing 
Block Design 
Rey-Osterrieth Complex Figure Task (Copy) 
Verbal Working Memory 
Letter-Number Sequencing 
Visual Working Memory 
Spatial Span 
Executive Functioning  
Trail-Making Test (Trail B) 
Stroop Task 
Attention 
Digit Span (Forward) 
Trail-Making Test (Trail A) 
 
32 
Table 3  
Group Differences by Cognitive Domain 
 
Domain t value df p value 
Effect  
Size (d) 
Mean 
z-score 
Std. Dev. 
 
Verbal Learning 
 
0.626 
 
48 
 
0.535 
 
0.177 
 
 
 
 
     Social Phobia Group 
     Control Group 
 
    -0.155 
0.000 
0.733 
0.999 
Verbal Delayed Memory 0.000 48 1.000 <0.001   
     Social Phobia Group 
     Control Group 
 
    0.000 
0.000 
0.983 
1.000 
Visual Immediate Memory 0.798 48 0.429 0.226   
     Social Phobia Group 
     Control Group 
 
    -0.232 
0.000 
1.052 
0.999 
Visual Delayed Memory 0.507 48 0.614 0.144   
     Social Phobia Group 
     Control Group 
 
    -0.139 
0.000 
0.934 
0.999 
Visual-Spatial Processing 0.257 48 0.798 0.072   
     Social Phobia Group 
     Control Group 
 
    0.070 
0.000 
1.075 
0.843 
Verbal Working Memory 0.582 48 0.563 0.165   
     Social Phobia Group 
     Control Group 
 
    -0.198 
0.000 
1.374 
0.999 
Visual Working Memory 2.043 48  0.047* 0.578   
     Social Phobia Group 
     Control Group 
 
    -0.506 
0.000 
0.728 
1.000 
Executive Functioning 1.090 48 0.281 0.308   
     Social Phobia Group 
     Control Group 
 
    0.271 
0.000 
0.931 
0.826 
Attention 1.033 48 0.307 0.293   
     Social Phobia Group 
     Control Group 
 
    0.171 
0.000 
0.617 
0.550 
     *p < .05 
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APPENDIX B: FIGURES 
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Figure 1 
Spatial Span Backward Score by Group 
 
______________________________________________________________________________ 
Boxes extend from the 25
th
 percentile to the 75
th
 percentile, with midlines marking the  
50
th
 percentile, based on that group‟s distribution 
Bars represent highest and lowest values that fall within 1.5 times the interquartile range 
 ○ indicates an outlier 
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Figure 2 
Group by SPAI-23 Difference Score Interaction on Spatial Span Forward Score 
 
______________________________________________________________________________ 
SPAI-23 Difference Score = SPAI-23 Social Phobia subscale – SPAI-23 Agoraphobia subscale 
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APPENDIX C: IRB APPROVAL LETTER
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University of Central Florida Institutional Review Board 
Office of Research & Commercialization 
12201 Research Parkway, Suite 501 
Orlando, Florida 32826-3246 
Telephone: 407-823-2901, 407-882-2901 or 407-882-2276 
www.research.ucf.edu/compliance/irb.html 
 
Notice of Expedited Initial Review and Approval 
 
From :   UCF Institutional Review Board 
FWA00000351, Exp. 5/07/10, IRB00001138 
 
To :   Scott Sutterby 
Date :   June 16, 2008 
 
IRB Number:  SBE-08-05628 
 
Study Title:  Neurocognitive Functioning in Social Phobia 
 
Dear Researcher: 
 
Your research protocol noted above was approved by expedited review by the UCF IRB Vice-chair on 6/16/2008. 
The expiration date is 6/15/2009. Your study was determined to be minimal risk for human subjects and 
expeditable per federal regulations, 45 CFR 46.110. The categories for which this study qualifies as expeditable 
research are as follows: 
 
6. Collection of data from voice, video, digital, or image recordings made for research purposes. 
 
7. Research on individual or group characteristics or behavior (including, but not limited to, research on  
perception, cognition, motivation, identity, language, communication, cultural beliefs or practices, and 
social behavior) or research employing survey, interview, oral history, focus group, program evaluation, 
human factors evaluation, or quality assurance methodologies. 
 
The IRB has approved a consent procedure which requires participants to sign consent forms. Use of the 
approved, stamped consent document(s) is required. Only approved investigators (or other approved key study 
personnel) may solicit consent for research participation. Subjects or their representatives must receive a copy of the 
consent form(s). 
 
All data, which may include signed consent form documents, must be retained in a locked file cabinet for a 
minimum of three years (six if HIPAA applies) past the completion of this research. Any links to the identification 
of participants should be maintained on a password-protected computer if electronic information is used. Additional 
requirements may be imposed by your funding agency, your department, or other entities. Access to data is limited 
to authorized individuals listed as key study personnel. 
 
To continue this research beyond the expiration date, a Continuing Review Form must be submitted 2 – 4 weeks 
prior to the expiration date. Advise the IRB if you receive a subpoena for the release of this information, or if a 
breach of confidentiality occurs. Also report any unanticipated problems or serious adverse events (within 5 working 
days). Do not make changes to the protocol methodology or consent form before obtaining IRB approval. Changes 
can be submitted for IRB review using the Addendum/Modification Request Form. An Addendum/Modification 
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Request Form cannot be used to extend the approval period of a study. All forms may be completed and submitted 
online at http://iris.research.ucf.edu. 
Failure to provide a continuing review report could lead to study suspension, a loss of funding and/or 
publication possibilities, or reporting of noncompliance to sponsors or funding agencies. The IRB maintains the 
authority under 45 CFR 46.110(e) to observe or have a third party observe the consent process and the research. 
 
On behalf of Tracy Dietz, Ph.D., UCF IRB Chair, this letter is signed by: 
 
Signature applied by Joanne Muratori on 06/16/2008 02:18:13 PM EDT 
 
IRB Coordinator 
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APPENDIX D: PHONE SCREEN  
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Phone Screen for Social Phobia Study 
Full name of Potential Participant: _______________________________ 
Phone Number: ________________ 
Interviewer Name: __________________________ 
Date of Phone Screen: ______________ 
“Hi.  My name is ________ and I‟m calling from the Psychology Department at the University 
of Central Florida in response to the phone message that you left, indicating interest in our 
research study. May I ask how you learned about our study?” (USE ANSWER TO 
DETERMINE WHETHER CONTROL OR SOCIAL PHOBIA GROUP) 
 
“Before I explain the study, we need to determine whether you are eligible for this particular 
study. What is your current age?” ________ (note: exclude if under 18 or over 65).   
 
Social Phobia Screen: 
 
 “In social situations where you might be observed or evaluated by others or when you are 
meeting new people, do you feel fearful, anxious, or nervous?” 
 
 “Are you overly concerned that you may do and/or say something that might embarrass 
or humiliate yourself in front of others, or that others may think badly of you?” 
 
If “YES” to either, consider for Social Phobia group – If “NO,” consider for Control group  
 
“To see if you are eligible, I will list a series of statements and, at the end of the list, you will say 
"yes" or "no" to indicate whether you would answer at least one of the items from the list as 
being true for you. In this way, we will not know which items from the list are true for you, in 
order to protect your confidentiality. Please think about each item after I read it, but only answer 
"yes" or "no" after I've read all items. Please answer “no” unless you are fairly sure that an item 
applies to you. Do you have any questions or concerns about this before I begin the list?” 
 
 
Exclusion List (Only get a "yes" or "no" at the very end of each list – NOT after each 
item): 
 "At some point in my life, I got hit in the head so hard that I blacked out for more than 10 
minutes." 
 "I've experienced one or more seizures after the age of 5." 
 "I've been diagnosed with a stroke, brain tumor, or other serious neurological disorder - 
like Parkinson‟s disease." 
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 "In the past month, I have used alcohol or drugs to the point that it affected my 
functioning at school, work, or personal relationships." 
 "During at least one point in my life, I received inpatient hospitalization for alcohol or 
drug dependence." 
 
"Without telling me which item, would you have answered "yes" to at least one item I just 
listed?"   YES    /    NO (IF YES, skip to below) 
 
"Now we will do the same thing with another list of items. Please remember to wait until the end 
of the list to indicate whether at least one of them applies to you." 
 "I currently have significant problems with my vision, even when wearing glasses or 
contacts." 
 "I have significant difficulty with moving or feeling the arm or hand that I use for 
writing." 
 “I have received electroconvulsive therapy in the past six months.” 
 
"Without telling me which item, would you have answered "yes" to at least one item I just 
listed?"   YES    /    NO (IF YES, skip to below) 
 
"Now we will do the same thing with one last set of items. Please remember to wait until the end 
of the list to indicate whether at least one of them applies to you." 
 
 “I have been diagnosed with AIDS, Lupus, congestive heart disease, or insulin-dependent 
diabetes.” 
 
 “I have been diagnosed with dyslexia or another specific learning disability.” 
 “English is not the first language that I spoke as a child.” 
 
"Without telling me which item, would you have answered "yes" to at least one item I just 
listed?"   YES    /    NO (IF YES, skip to below) 
 
If "YES" to any list above  – "Thank you for your openness with this procedure. Unfortunately, 
you do not qualify for this particular study because you endorsed at least one of these factors 
which could influence your performance on the tasks in our study. We appreciate your time 
completing this brief phone screen. Do you have any questions I can address?" 
 
IF "NO" – "Thanks for going through this list with me. It sounds like you qualify for 
participation in our study. Can I give you a brief overview of what the study involves, so that you 
can decide if you'd like to participate?" 
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If Control Group: 
“We are conducting a study to examine differences in thinking ability and perception as it relates 
to social anxiety. We are interested in having you participate in a community comparison group 
so that we can look at differences in your performance with the performance of individuals who 
experience intense anxiety or fear in social situations. We hope to gain information that may lead 
to better treatment for social anxiety.” 
 
If Social Phobia Group: 
“We are conducting a study to examine differences in thinking ability and perception as it relates 
to social anxiety. We are interested in having you participate in the group of individuals who 
experience anxiety in social situations. We hope to gain information that may one day lead to 
better treatment for social anxiety.” 
 
All Groups: 
"The study will take place in our research laboratory in the Psychology Building on the main 
campus of the University of Central Florida in east Orlando. You will be provided with detailed 
directions and free parking in front of the building. During this meeting, we will interview you 
about your mental and physical health and you will be asked to complete some questionnaires 
about psychological experiences you may have had. After this interview, we will ask you to 
complete a series of thinking ability and perception tasks. All information you provide will 
remain strictly confidential. Your name will not be used in any report or presentation. This 
meeting would last about 2.5 hours. You will be paid by check at the end of the meeting at the 
rate of $10 for each 30 minutes of participation, so you can expect to be paid approximately $50, 
although the exact time and amount may vary slightly for each participant. 
 
"Are there any questions or concerns about that I can address for you?"   
 
"Are you willing to participate, with the understanding that you can discontinue participation at 
any point, for any reason, without penalty?" 
IF SO – schedule date and time: ____________________________ 
 
"I have a map and directions to send you to help you find our building. Would you prefer that I 
e-mail, fax, or mail these to you?" (INCLUDE INFORMATION BELOW) - Send our cover 
letter with appointment date and time, along with map/directions. 
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